TRIM33 and dermatomyositis: According to these previous reports, in the paper by Seto et al, the circulating NETs remnants measured as the NE-DNA and MPO-DNA complexes were increased in patients with DM and JDM and in those with positive anti-MDA5 and anti-TIF1-γ antibodies (10).